Medica represents the world's largest medical device show which takes place every November in Düsseldorf Germany. Due to the Coronavirus this event has had to go virtual in 2020. As a result, Zenit along with enterprise europe network have created a virtual brokerage and education platform which will allow thousands of participants to come together and benefit from one another. [...]
Cerebriu, a Danish medical technology start-up focused on faster, personalized diagnostic imaging, engaged BioPort to help them identify a U.S. Radiology Department to conduct a pre-FDA pilot. We were fortunate enough to work with the leadership at SUNY Upstate to gain the interest of the Neuroradiology Department including Dr. Sylvie Destian. They have not only agreed to participate in a Retrospective Study pre-FDA but also be involved in a Prospective Clinical Trial to help achieve FDA approval.[...]
Wilco invited BioPortUSA to present to a group of French medtech companies from across France. The one-time special event is scheduled for Tuesday, September 29.[...]
Demystifying market entry into the USA: What steps to take to successfully navigate the US healthcare market. More than ever, healthcare plays a critical role in the United States. But what does this mean for providers of medical technology products or solutions in Baden-Württemberg?[...]
BioPortUSA is extremely excited to announce the addition of two new clients who are both involved in the fight against Covid-19.[...]
MAP BioPharma is a U.K. based life science consultancy that works with several partners who share their vision to accelerate patient access and support Pharmaceutical and MedTech companies in reaching patients sooner with their medicines, devices, and diagnostics. Christian Hill, CEO & Co-Founder of MAP BioPharma says that “BioPortUSA facilitates entry for overseas-life sciences companies into the United States so are a natural fit and addition to MAP’s network and we look forward to working with them to support our clients”. MAP BioPharm’s extensive knowledge of the European healthcare environment provides strategic guidance for successful European Market entry. Operating in a diverse market requires careful consideration. Their team will guide you through the necessary steps and provide a blueprint to ensure that you have covered all the requirements for the European Market. Christian has built a solid company, with an incredible network that will no doubt benefit our clients who are looking to go overseas. We in turn look forward to supporting MAPBioPharma clients who are looking to gain entry into the USA’’ says CEO & Founder Mark Lesselroth. [...]
European Medical Market Access Network (EUMMAN) has invited BioPortUSA to present a webinar on market entry USA to their clients on Monday, June 8th, 2020. Mark Lesselroth, CEO of BioPort will talk about what it takes to be successful in the U.S. Healthcare market and what steps one should take before considering entering the market.[...]
BioPortUSA has been invited to present to a group of Danish medtech start-ups on Thursday, May 21st on market entry USA. The focal point will be on how these companies can access the market efficiently and successfully by reviewing a step-process BioPort has developed.[...]
Social Media
